Context Therapeutics Inc (CNTX) Directors and Executive Officers - CSIMarket
CSIMarket
 
Context Therapeutics Inc   (NASDAQ: CNTX)

Context Therapeutics Inc

Officers & Directors


Martin Lehr
- Chief Executive Officer and Director (Principal Executive Officer)

Philip Kantoff
- Director

Linda West
- Director

Richard Berman
- Chairman of the Board and Director

Jennifer Evans Stacey
- Director

Jennifer Minai-Azary
- Chief Financial Officer (Principal Financial and Accounting Officer)

CohnRenzick LLP
- Auditor since - ,

Context Therapeutics Inc currently has 15 employees.

  News about Context Therapeutics Inc Key Personnel

Context Therapeutics: Bridging Challenges with Innovation in the Fight Against Cancer,

The Evolution of Cancer Treatment: Context Therapeutics Enters a New Era with Strategic Leadership and Innovative TherapiesIn an era where the quest for effective cancer treatments is both urgent and dynamic, Context Therapeutics Inc. is making significant strides toward becoming a key player in the biopharmaceutical landscape. Recent leadership appointments and upcoming presentations at major conferences underscore the company’s strategic vision and commitment to tackling solid tumors through advanced immune therapies.New Leadership and Financial RealityContext Therapeutics has appointed Andy Pasternak as the Chairman of the Board of Directors, a significant move that brings decades of global pharmaceuti...






CNTX Management Effectiveness CNTX Revenue per Employee CNTX Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.